NEWS FEED & ADDITIVE MAGAZINE January 2023 17 Elinor McCartney, founder of Pen & Tec, said: “Becoming part of Argenta provides our clients with access to a full range of services and solutions to get their products to market, and guarantees long-term business continuity for our customers as well as attractive career development opportunities for our global employee base and future talent. I am eager to continue our legacy as part of Argenta and am confident in a bright future together.” Going forward, we will be able to provide a complex, full range of services to assist our customers with their Molecule to Market ideas. Pen & Tec, as a part of the Argenta Group, will be able to cover the needs of our customers in the following areas as well: • The evaluation of market potential and strategic opportunities • Testing of the molecular entity to evaluate pilot efficacy and safety • Testing of the final formulation to evaluate pivotal clinical studies • Fully support the safeguarding the quality of the product from R&D to commercialisation • Commercial manufacturing in one of the three GMP-certified sites in New Zealand, the UK and the US Ing. Justyna Pałasińska, Regulatory Affairs Director – Human Nutrition, said: “Argenta is focused on animal health and nutrition. Nevertheless, I believe that they will be able to provide added value to Pen & Tec food clients as well. Their experience in manufacturing & product development can surely be extrapolated onto the food side, especially in regard to novel foods. I also look forward to introducing Argenta to the world of human nutrition & how we can grow in this area together.” Argenta together with their newly acquired business partners will be in London from 6-8 March, 2023 at the Animal Health, Nutrition and Technology Innovation Europe Summit hosted by Kisaco. As an Associate Sponsor of this prestigious summit, Argenta will be hosting a workshop on “A strategic approach to early-stage product development”. During this workshop, potential customers can: • get a perspective of early-stage development strategy in the area of their choice: veterinary medicinal products, animal nutrition, or medical devices. • gain clarity around the pre-clinical, clinical and regulatory requirements in the EU and the US market and the process for achieving approval • acquire insights on when and how to select the right partner(s) or strategic alliances to accelerate the development of your product We are excited to announce that the speakers for the event will be Dr Elinor McCartney, Founder of Pen & Tec Consulting; Dr Klaus Hellmann, founder of Klifovet as well as Dr Patxi Sarasola, Managing Director of Ondax Scientific. The speakers will also highlight the challenges of the economic downturn on clinical studies and discuss potential solutions. If you are considering attending this event, we invite you to join us at the workshop and meet out experts in person. We encourage customers to get in contact as this will be the first step in discovering new opportunities for their business. Our team is standing by to offer tailored solutions and exceptional service. Customers can keep in touch with us through multiple channels. Make sure to subscribe to our newsletter and stay up to date on the latest from Pen & Tec as well as news from the industry. We are active on social media and customers can follow us on Linkedin, Twitter as well as Youtube. Apart from regulatory services, we also host training sessions for the industry in the form of seminars and training video courses. We are excited for what the future holds and believe that this new acquisition will be an invaluable partner for animal health and nutrition customers globally. SPECIAL
RkJQdWJsaXNoZXIy MTUxNjkxNQ==